<p>The Office of Cancer Genomics at the National Cancer Institute sponsored a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing technologies  in cancer. The CGCI program included comprehensive characterization of the genetic aberrations found in different pediatric and/or adult tumors. All</p>

National Cancer Institute (NCI) Cancer Genome Characterization Initiative    (CGCI): HIV+ Tumor Molecular Characterization Project - Lung Cancer    (HTMCP - LC)

Lymphoma, AIDS-Related study with RNA-Seq, WGS + 1 more data on CRDC (39 participants)

phs000530 — National Cancer Institute (NCI) Cancer Genome Characterization Initiative    (CGCI): HIV+ Tumor Molecular Characterization Project - Lung Cancer    (HTMCP - LC)

National Cancer Institute (NCI) Cancer Genome Characterization Initiative (CGCI): HIV+ Tumor Molecular Characterization Project - Lung Cancer (HTMCP - LC)

Description

Applying For Access

Summary